- Name of issuer: HaTay Pharmaceutical JSC
- Stock code: DHT
- Securities type: Common stock
- Name of connected institution: ASKA PHARMACEUTICAL CO.,LTD.
- Name of person discharging managerial responsibility (PDMR)/Director: Hiroyasu Nishioka
- Position in the listed company: Director
- Position in the trading institution: Executive Manager
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 0 shares (0%)
- Name of person discharging managerial responsibility (PDMR)/Director: Keisuke Oshio
- Position in the listed company: Director
- Position in the trading institution: Other
- Number of shares held by person discharging managerial responsibility (PDMR)/Director: 0 shares (0%)
- Number of shares held by connected institution before transaction: 32,885,239 shares (39.94%)
- Number of shares to be acquired: 90,000 shares
- Nature of transaction: Order matching & Put-through
- Purpose of transaction: Increasing shareholding rate
- Expected Start date of transaction: 07/02/2025
- Expected End date of transaction: 07/03/2025